Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma

NCT02658019 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Pembrolizumab

Sponsor

Lynn Feun, MD

Collaborators

[object Object]